Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Whole Exome Sequencing Identifies APCDD1 and HDAC5 Genes as Potentially Cancer Predisposing in Familial Colorectal Cancer

D. Skopelitou, B. Miao, A. Srivastava, A. Kumar, M. Kuswick, D. Dymerska, N. Paramasivam, M. Schlesner, J. Lubinski, K. Hemminki, A. Försti, OR. Bandapalli

. 2021 ; 22 (4) : . [pub] 20210212

Language English Country Switzerland

Document type Clinical Trial, Journal Article

Persistent link   https://www.medvik.cz/link/bmc21019255

Grant support
COST Action CA17118 European Cooperation in Science and Technology
Transcan ERA-NET funding Bundesministerium für Bildung und Forschung
grant No. 856620 Horizon 2020

Germline mutations in predisposition genes account for only 20% of all familial colorectal cancers (CRC) and the remaining genetic burden may be due to rare high- to moderate-penetrance germline variants that are not explored. With the aim of identifying such potential cancer-predisposing variants, we performed whole exome sequencing on three CRC cases and three unaffected members of a Polish family and identified two novel heterozygous variants: a coding variant in APC downregulated 1 gene (APCDD1, p.R299H) and a non-coding variant in the 5' untranslated region (UTR) of histone deacetylase 5 gene (HDAC5). Sanger sequencing confirmed the variants segregating with the disease and Taqman assays revealed 8 additional APCDD1 variants in a cohort of 1705 familial CRC patients and no further HDAC5 variants. Proliferation assays indicated an insignificant proliferative impact for the APCDD1 variant. Luciferase reporter assays using the HDAC5 variant resulted in an enhanced promoter activity. Targeting of transcription factor binding sites of SNAI-2 and TCF4 interrupted by the HDAC5 variant showed a significant impact of TCF4 on promoter activity of mutated HDAC5. Our findings contribute not only to the identification of unrecognized genetic causes of familial CRC but also underline the importance of 5'UTR variants affecting transcriptional regulation and the pathogenesis of complex disorders.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019255
003      
CZ-PrNML
005      
20210830100832.0
007      
ta
008      
210728s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms22041837 $2 doi
035    __
$a (PubMed)33673279
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Skopelitou, Diamanto $u Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany $u Medical Faculty, Heidelberg University, 69120 Heidelberg, Germany
245    10
$a Whole Exome Sequencing Identifies APCDD1 and HDAC5 Genes as Potentially Cancer Predisposing in Familial Colorectal Cancer / $c D. Skopelitou, B. Miao, A. Srivastava, A. Kumar, M. Kuswick, D. Dymerska, N. Paramasivam, M. Schlesner, J. Lubinski, K. Hemminki, A. Försti, OR. Bandapalli
520    9_
$a Germline mutations in predisposition genes account for only 20% of all familial colorectal cancers (CRC) and the remaining genetic burden may be due to rare high- to moderate-penetrance germline variants that are not explored. With the aim of identifying such potential cancer-predisposing variants, we performed whole exome sequencing on three CRC cases and three unaffected members of a Polish family and identified two novel heterozygous variants: a coding variant in APC downregulated 1 gene (APCDD1, p.R299H) and a non-coding variant in the 5' untranslated region (UTR) of histone deacetylase 5 gene (HDAC5). Sanger sequencing confirmed the variants segregating with the disease and Taqman assays revealed 8 additional APCDD1 variants in a cohort of 1705 familial CRC patients and no further HDAC5 variants. Proliferation assays indicated an insignificant proliferative impact for the APCDD1 variant. Luciferase reporter assays using the HDAC5 variant resulted in an enhanced promoter activity. Targeting of transcription factor binding sites of SNAI-2 and TCF4 interrupted by the HDAC5 variant showed a significant impact of TCF4 on promoter activity of mutated HDAC5. Our findings contribute not only to the identification of unrecognized genetic causes of familial CRC but also underline the importance of 5'UTR variants affecting transcriptional regulation and the pathogenesis of complex disorders.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a kolorektální nádory $x genetika $7 D015179
650    _2
$a ženské pohlaví $7 D005260
650    12
$a genetická predispozice k nemoci $7 D020022
650    12
$a zárodečné mutace $7 D018095
650    _2
$a histondeacetylasy $x genetika $7 D006655
650    _2
$a lidé $7 D006801
650    _2
$a intracelulární signální peptidy a proteiny $x genetika $7 D047908
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a membránové proteiny $x genetika $7 D008565
650    _2
$a lidé středního věku $7 D008875
650    12
$a sekvenování exomu $7 D000073359
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
700    1_
$a Miao, Beiping $u Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany
700    1_
$a Srivastava, Aayushi $u Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany $u Medical Faculty, Heidelberg University, 69120 Heidelberg, Germany
700    1_
$a Kumar, Abhishek $u Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Institute of Bioinformatics, International Technology Park, Bangalore 560066, India $u Manipal Academy of Higher Education (MAHE), Manipal 576104, India
700    1_
$a Kuswick, Magdalena $u Department of Genetics and Pathology, Pomeranian Medical University, 71252 Szczecin, Poland
700    1_
$a Dymerska, Dagmara $u Department of Genetics and Pathology, Pomeranian Medical University, 71252 Szczecin, Poland
700    1_
$a Paramasivam, Nagarajan $u Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany
700    1_
$a Schlesner, Matthias $u Bioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
700    1_
$a Lubinski, Jan $u Department of Genetics and Pathology, Pomeranian Medical University, 71252 Szczecin, Poland
700    1_
$a Hemminki, Kari $u Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague, 30605 Pilsen, Czech Republic
700    1_
$a Försti, Asta $u Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany
700    1_
$a Bandapalli, Obul Reddy $u Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany $u Medical Faculty, Heidelberg University, 69120 Heidelberg, Germany
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 4 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33673279 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100832 $b ABA008
999    __
$a ok $b bmc $g 1690149 $s 1139701
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 22 $c 4 $e 20210212 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a COST Action CA17118 $p European Cooperation in Science and Technology
GRA    __
$a Transcan ERA-NET funding $p Bundesministerium für Bildung und Forschung
GRA    __
$a grant No. 856620 $p Horizon 2020
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Archiving options